Modified siRNA molecules and uses thereof
First Claim
1. A method for generating a chemically modified double-stranded short interfering nucleic acid (siNA) molecule that directs cleavage of a target RNA via RNA interference and has reduced immunostimulatory properties compared to a corresponding siNA molecule having unmodified nucleotides, said method comprising:
- (a) introducing 2′
-O-methyl (2′
OMe) nucleotides in one or more of the nucleotide positions of the siNA molecule, wherein(i) each strand of said siNA molecule is about 18 to about 38 nucleotides in length;
(ii) one strand of said siNA molecule comprises a nucleotide sequence having sufficient complementarity to said target RNA for the siNA molecule to direct cleavage of the target RNA via RNA interference;
(iii) said siNA molecule does not comprise phosphorothioate backbone modifications; and
(iv) said 2′
OMe nucleotides are not 2′
OMe-cytosine nucleotides; and
(b) assaying the siNA molecule of step (a) under conditions suitable for isolating an siNA molecule having reduced immunostimulatory properties compared to a corresponding siNA molecule having unmodified nucleotides wherein said reduced immunostimulatory properties comprise an abrogated or reduced induction of inflammatory or pro-inflammatory cytokines and/or an abrogated or reduced induction of Toll Like Receptors (TLRs) in response to the siNA being introduced in a cell, tissue, or organism.
4 Assignments
0 Petitions
Accused Products
Abstract
The present invention provides chemically modified siRNA molecules and methods of using such siRNA molecules to silence target gene expression. Advantageously, the modified siRNA of the present invention is less immunostimulatory than its corresponding unmodified siRNA sequence and retains full RNAi activity against the target sequence. The present invention also provides nucleic acid-lipid particles comprising a modified siRNA, a cationic lipid, and a non-cationic lipid, which can further comprise a conjugated lipid that inhibits aggregation of particles. Methods for identifying and/or modifying an siRNA having immunostimulatory properties are also provided.
120 Citations
11 Claims
-
1. A method for generating a chemically modified double-stranded short interfering nucleic acid (siNA) molecule that directs cleavage of a target RNA via RNA interference and has reduced immunostimulatory properties compared to a corresponding siNA molecule having unmodified nucleotides, said method comprising:
-
(a) introducing 2′
-O-methyl (2′
OMe) nucleotides in one or more of the nucleotide positions of the siNA molecule, wherein(i) each strand of said siNA molecule is about 18 to about 38 nucleotides in length; (ii) one strand of said siNA molecule comprises a nucleotide sequence having sufficient complementarity to said target RNA for the siNA molecule to direct cleavage of the target RNA via RNA interference; (iii) said siNA molecule does not comprise phosphorothioate backbone modifications; and (iv) said 2′
OMe nucleotides are not 2′
OMe-cytosine nucleotides; and(b) assaying the siNA molecule of step (a) under conditions suitable for isolating an siNA molecule having reduced immunostimulatory properties compared to a corresponding siNA molecule having unmodified nucleotides wherein said reduced immunostimulatory properties comprise an abrogated or reduced induction of inflammatory or pro-inflammatory cytokines and/or an abrogated or reduced induction of Toll Like Receptors (TLRs) in response to the siNA being introduced in a cell, tissue, or organism. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11)
-
Specification